TY-2699a

N/A

Report date: 2023/05/16 14:31:24
NME

Base Information

Drug NameTY-2699a
Drug Alias NameTY-2699a
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7
Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaTriple Negative Breast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTYK Medicines Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTYK Medicines Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsSmall Cell Lung CarcinomaTriple Negative Breast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A